Named patient pharmaceutical assessment (NPPA) policy consultation
PHARMAC has reviewed our Named Patient Pharmaceutical Assessment (NPPA) Policy as part of a rolling review of our operating policies and procedures (OPP). The outcome of this review was a new decision-making framework that was introduced in the second half of 2015.
Introducing the Exceptional Circumstances Framework
The new Exceptional Circumstances Framework includes:
- the revised NPPA Policy
- other exceptions, including
- Special Authority waivers
- Hospital Medicine Restriction waivers.
Exceptional Circumstances Framework
The consultation and review showed that the intent of the NPPA Policy remains sound. However, we received feedback that the NPPA Policy is difficult to interpret and apply, and the application process could be cumbersome. We’ve gone back to the core principles of the NPPA Policy and rewritten it to make it clearer.
NPPA Policy consultation
The NPPA Policy review started in April 2014, and included a round of public consultation which ran for 4 weeks.
Last updated: 18 September 2017